Taking stock: A change in the weather

Share on facebook
Share on twitter
Share on linkedin

“A change in the weather is known to be extreme,
But what’s the sense of changing horses in midstream?”

Bob Dylan, You’re a Big Girl Now, 1975

Across the RWC European and UK Equity team’s mandates, performance has been positive so far this year, with overweight exposures to the sectors that have tended to deliver the best returns, and an additional benefit coming through from successful stock selection. Meanwhile, our natural bias towards mid-cap stocks – those still large enough to offer decent liquidity, but small enough to avoid a broad following from the investment community, has also added value.

Nevertheless, although these trends had been beneficial to performance over 2020 as a whole, they have been unhelpful in recent days. In particular, last week saw a tangible rotation, with some of the stocks that have done well for the portfolios year-to-date, underperforming. This has been unhelpful in the short-term, albeit mitigated to an extent by a more positive performance from some of the portfolio’s 2020 laggards. The same trends have been evident across European equity markets more broadly in recent trading sessions.

We believe that a disciplined response is sensible in a situation like this. There is an obvious difference between a change in the weather (seasonal, short-term and highly predictable) and a change in the climate (complex, longer term and much harder to predict). Naturally, given the long-term nature of our investment approach, we are more concerned about shifts in the longer-term investment climate, than we are to the prevailing weather conditions as they change on a day-to-day basis.

A short period of more challenged performance is never comfortable to endure, but that does not necessarily mean that a change to the strategy is warranted. It is, however, an opportunity to revisit our fundamental thinking for each position and judge if the longer-term thesis still holds valid. If it does, there may be an opportunity to exploit the change in the weather by adding to the position at an even more favourable price.

Our sense currently is that this most recent rotation will be short-lived. It isn’t the first time this year that equity markets have seen a temporary reversal of enduring trends, and it may not be the last. From a fundamental perspective, however, we remain confident that our over-arching strategy remains relevant and appropriate for the current investment climate. In our view, this is a time to be watchful rather than overly active, but we will continue to tweak the portfolios to maintain their optimal shape.

This week’s highlights

As an example of the trends referred to above, the Spanish testing business Applus has been one of the portfolios’ weakest positions year-to-date. We have frequently revisited the fundamentals and have repeatedly concluded that our long-term investment thesis is not broken. Hence, in the face of obvious weakness in its industrial end markets during lockdown, we have maintained exposure to the business. Last week, Applus announced the acquisition of Besikta, a complementary Swedish business, in a deal that provided a welcome boost to its share price. Applus doesn’t need to raise equity to finance the acquisition, which has reassured investors about the company’s balance sheet and prospects. We believe that Applus can deliver modest but sustainable organic growth rates from here, which can continue to be augmented through further bolt-on acquisitions, as it consolidates a fragmented industry.

Global consumer staples business, Reckitt Benckiser, also performed well last week, following a decent Q3 trading update, which showed better-than-expected organic growth rates and contained an upgrade to its full-year guidance. Coming into 2020, with a new chief executive in place, we viewed Reckitt’s as a stock that had the ability to deliver consensus-beating growth rates. The pandemic has delivered an additional boost to revenue through the sale of considerably more disinfectant and cleaning products. From here, many analysts are questioning how long this additional Covid boost will last. Consensus revenue forecasts are flat for 2021 but, with the virus likely to remain with us for some time and the potential for a broader contribution from other parts of the business as the new CEO’s initiatives bear fruit, we are anticipating continued growth in the years ahead.

French healthcare business, Ipsen, delivered Q3 results last week, which were broadly in line with expectations. Results from its oncology division were slightly disappointing, with patient numbers lower than anticipated because hospitals have inevitably been focused on treating Covid patients. Ultimately, this is a temporary problem and our longer term confidence in Ipsen’s oncology business remains robust. More positively, expectations for a treatment for a very rare but potentially fatal bone disorder, have started to improve. Palovarotene was put on clinical hold in January, which led to a sharp fall in its share price and an opportunity for us to add this position to the portfolios as a recovery play. The most recent update on the asset suggests the probability of a commercial launch is now improving again, which is positive news for the share price and for patients.

Unless otherwise stated, all opinions within this document are those of the RWC European and UK Equity Team, as at 28th October 2020.

The names shown above are for illustrative purposes only and is not intended to be, and should not be interpreted as, recommendations or advice.

The term “RWC” may include any one or more RWC branded entities including RWC Partners Limited and RWC Asset Management LLP, each of which is authorised and regulated by the UK Financial Conduct Authority and, in the case of RWC Asset Management LLP, the US Securities and Exchange Commission; RWC Asset Advisors (US) LLC, which is registered with the US Securities and Exchange Commission; and RWC Singapore (Pte) Limited, which is licensed as a Licensed Fund Management Company by the Monetary Authority of Singapore.

RWC may act as investment manager or adviser, or otherwise provide services, to more than one product pursuing a similar investment strategy or focus to the product detailed in this document. RWC seeks to minimise any conflicts of interest, and endeavours to act at all times in accordance with its legal and regulatory obligations as well as its own policies and codes of conduct.

This document is directed only at professional, institutional, wholesale or qualified investors. The services provided by RWC are available only to such persons. It is not intended for distribution to and should not be relied on by any person who would qualify as a retail or individual investor in any jurisdiction or for distribution to, or use by, any person or entity in any jurisdiction where such distribution or use would be contrary to local law or regulation.

This document has been prepared for general information purposes only and has not been delivered for registration in any jurisdiction nor has its content been reviewed or approved by any regulatory authority in any jurisdiction. The information contained herein does not constitute: (i) a binding legal agreement; (ii) legal, regulatory, tax, accounting or other advice; (iii) an offer, recommendation or solicitation to buy or sell shares in any fund, security, commodity, financial instrument or derivative linked to, or otherwise included in a portfolio managed or advised by RWC; or (iv) an offer to enter into any other transaction whatsoever (each a “Transaction”). No representations and/or warranties are made that the information contained herein is either up to date and/or accurate and is not intended to be used or relied upon by any counterparty, investor or any other third party.

RWC uses information from third party vendors, such as statistical and other data, that it believes to be reliable. However, the accuracy of this data, which may be used to calculate results or otherwise compile data that finds its way over time into RWC research data stored on its systems, is not guaranteed. If such information is not accurate, some of the conclusions reached or statements made may be adversely affected. RWC bears no responsibility for your investment research and/or investment decisions and you should consult your own lawyer, accountant, tax adviser or other professional adviser before entering into any Transaction. Any opinion expressed herein, which may be subjective in nature, may not be shared by all directors, officers, employees, or representatives of RWC and may be subject to change without notice. RWC is not liable for any decisions made or actions or inactions taken by you or others based on the contents of this document and neither RWC nor any of its directors, officers, employees, or representatives (including affiliates) accepts any liability whatsoever for any errors and/or omissions or for any direct, indirect, special, incidental, or consequential loss, damages, or expenses of any kind howsoever arising from the use of, or reliance on, any information contained herein.

Information contained in this document should not be viewed as indicative of future results. Past performance of any Transaction is not indicative of future results. The value of investments can go down as well as up. Certain assumptions and forward looking statements may have been made either for modelling purposes, to simplify the presentation and/or calculation of any projections or estimates contained herein and RWC does not represent that that any such assumptions or statements will reflect actual future events or that all assumptions have been considered or stated. Forward-looking statements are inherently uncertain, and changing factors such as those affecting the markets generally, or those affecting particular industries or issuers, may cause results to differ from those discussed. Accordingly, there can be no assurance that estimated returns or projections will be realised or that actual returns or performance results will not materially differ from those estimated herein. Some of the information contained in this document may be aggregated data of Transactions executed by RWC that has been compiled so as not to identify the underlying Transactions of any particular customer.

The information transmitted is intended only for the person or entity to which it has been given and may contain confidential and/or privileged material. In accepting receipt of the information transmitted you agree that you and/or your affiliates, partners, directors, officers and employees, as applicable, will keep all information strictly confidential. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information is prohibited. The information contained herein is confidential and is intended for the exclusive use of the intended recipient(s) to which this document has been provided. Any distribution or reproduction of this document is not authorised and is prohibited without the express written consent of RWC or any of its affiliates.

Changes in rates of exchange may cause the value of such investments to fluctuate. An investor may not be able to get back the amount invested and the loss on realisation may be very high and could result in a substantial or complete loss of the investment. In addition, an investor who realises their investment in a RWC-managed fund after a short period may not realise the amount originally invested as a result of charges made on the issue and/or redemption of such investment. The value of such interests for the purposes of purchases may differ from their value for the purpose of redemptions. No representations or warranties of any kind are intended or should be inferred with respect to the economic return from, or the tax consequences of, an investment in a RWC-managed fund. Current tax levels and reliefs may change. Depending on individual circumstances, this may affect investment returns. Nothing in this document constitutes advice on the merits of buying or selling a particular investment. This document expresses no views as to the suitability or appropriateness of the fund or any other investments described herein to the individual circumstances of any recipient.

AIFMD and Distribution in the European Economic Area (“EEA”)

The Alternative Fund Managers Directive (Directive 2011/61/EU) (“AIFMD”) is a regulatory regime which came into full effect in the EEA on 22 July 2014. RWC Asset Management LLP is an Alternative Investment Fund Manager (an “AIFM”) to certain funds managed by it (each an “AIF”). The AIFM is required to make available to investors certain prescribed information prior to their investment in an AIF. The majority of the prescribed information is contained in the latest Offering Document of the AIF. The remainder of the prescribed information is contained in the relevant AIF’s annual report and accounts. All of the information is provided in accordance with the AIFMD.

In relation to each member state of the EEA (each a “Member State”), this document may only be distributed and shares in a RWC fund (“Shares”) may only be offered and placed to the extent that (a) the relevant RWC fund is permitted to be marketed to professional investors in accordance with the AIFMD (as implemented into the local law/regulation of the relevant Member State); or (b) this document may otherwise be lawfully distributed and the Shares may lawfully offered or placed in that Member State (including at the initiative of the investor).

Information Required for Distribution of Foreign Collective Investment Schemes to Qualified Investors in Switzerland

The representative and paying agent of the RWC-managed funds in Switzerland (the “Representative in Switzerland”) is Société Générale, Paris, Zurich Branch, Talacker 50,

P.O. Box 5070, CH-8021 Zurich. In respect of the units of the RWC-managed funds distributed in Switzerland, the place of performance and jurisdiction is at the registered office of the Representative in Switzerland.

Explore more

Taking stock: Tech-tonic shifts

Dealing with a large and diverse investment universe, such as the one that Europe’s collective equity markets represents…

Taking stock: You’re due an upgrade

We have seen a number of positive profit warnings across the portfolio in recent weeks, which in aggregate, have had a beneficial impact on performance…

Taking stock: Catching falling knives

There is a regularly used phrase in financial markets, which becomes particularly popular in times of market stress: “Don’t catch falling knives”…

Taking stock: Where to from here?

European stock markets appear to lack direction at the moment. Following the steep sell-off in Q1 as the coronavirus crisis gripped global financial markets…


Please confirm your investor type



By clicking Submit, you agree that you have read and accepted the terms and conditions detailed in the DISCLAIMER

This website uses cookies. A cookie is a small data file placed on your computer which captures information about your choices which allows us to improve your experience of the website, for example, by remembering your country of residence. By continuing to access this website, you agree to be bound by our Cookie Policy. You can accept and/or block at any time by changing your browser settings.


Where are you located?



Rest of world

By clicking Submit, you agree that you have read and accepted the terms and conditions detailed in the DISCLAIMER


What type of investor are you?



By clicking Submit, you agree that you have read and accepted the terms and conditions detailed in the DISCLAIMER